NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, announced today that it will announce financial results for the third quarter ended September 30, 2008 after the close of the U.S. financial markets on Thursday, November 6, 2008. An accompanying conference call to discuss the results will be held the same day at 4:30 pm ET; 1:30 pm PT.
